0001753926-24-001133.txt : 20240618
0001753926-24-001133.hdr.sgml : 20240618
20240618200345
ACCESSION NUMBER: 0001753926-24-001133
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240614
FILED AS OF DATE: 20240618
DATE AS OF CHANGE: 20240618
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Friedberg Ezra M
CENTRAL INDEX KEY: 0001679440
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41964
FILM NUMBER: 241053678
MAIL ADDRESS:
STREET 1: 1000 MARINA BOULEVARD
STREET 2: SUITE 250
CITY: BRISBANE
STATE: CA
ZIP: 94005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Chromocell Therapeutics Corp
CENTRAL INDEX KEY: 0001919246
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 863335449
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 685 US HIGHWAY ONE
CITY: NORTH BRUNSWICK
STATE: NJ
ZIP: 08902
BUSINESS PHONE: 9176446313
MAIL ADDRESS:
STREET 1: 685 US HIGHWAY ONE
CITY: NORTH BRUNSWICK
STATE: NJ
ZIP: 08902
4
1
ownership.xml
X0508
4
2024-06-14
0
0001919246
Chromocell Therapeutics Corp
CHRO
0001679440
Friedberg Ezra M
C/O CHROMOCELL THERAPEUTICS CORPORATION
4400 ROUTE 9 SOUTH, SUITE 1000
FREEHOLD
NJ
07728
1
0
0
0
0
Restricted Stock Units
1.30
2024-06-14
4
A
0
64498
A
2034-06-14
Common Stock
64498
610219
D
On June 14, 2024, the Reporting Person was granted restricted stock units to purchase 64,498 shares of common stock at an exercise price of $1.30 per share, which shall vest on a quarterly basis over a period of two (2) years.
/s/ Ezra Friedberg
2024-06-18